{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T10:45:29Z","timestamp":1793616329329,"version":"4.5.0"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,11,14]],"date-time":"2023-11-14T00:00:00Z","timestamp":1699920000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100012543","name":"Shanghai Science and Technology Development Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012543","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011488","name":"Shanghai Pudong New Area Health Commission","doi-asserted-by":"publisher","award":["PKJ2021-Y07"],"award-info":[{"award-number":["PKJ2021-Y07"]}],"id":[{"id":"10.13039\/501100011488","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011488","name":"Shanghai Pudong New Area Health Commission","doi-asserted-by":"publisher","award":["PWYgy2021-05"],"award-info":[{"award-number":["PWYgy2021-05"]}],"id":[{"id":"10.13039\/501100011488","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/j.intimp.2023.111195","type":"journal-article","created":{"date-parts":[[2023,12,3]],"date-time":"2023-12-03T21:28:39Z","timestamp":1701638919000},"page":"111195","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"special_numbering":"C","title":["PCSK9 inhibitor protects against ischemic cerebral injury by attenuating inflammation via the GPNMB\/CD44 pathway"],"prefix":"10.1016","volume":"126","author":[{"given":"Yaling","family":"Zheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianrui","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luran","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-2497-4161","authenticated-orcid":false,"given":"Yue","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2023.111195_b0005","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/S1474-4422(04)00800-2","article-title":"The global stroke initiative","volume":"3","author":"Bonita","year":"2004","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.intimp.2023.111195_b0010","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1038\/nature04481","article-title":"From angiogenesis to neuropathology","volume":"438","author":"Greenberg","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.intimp.2023.111195_b0015","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1177\/2396987318786023","article-title":"Access to and delivery of acute ischaemic stroke treatments: A survey of national scientific societies and stroke experts in 44 European countries","volume":"4","author":"Aguiar de Sousa","year":"2019","journal-title":"Eur Stroke J."},{"key":"10.1016\/j.intimp.2023.111195_b0020","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1038\/nm.2399","article-title":"The immunology of stroke: from mechanisms to translation","volume":"17","author":"Iadecola","year":"2011","journal-title":"Nat. Med."},{"key":"10.1016\/j.intimp.2023.111195_b0025","doi-asserted-by":"crossref","first-page":"294","DOI":"10.3389\/fimmu.2020.00294","article-title":"Glial Cells: Role of the Immune Response in Ischemic Stroke","volume":"11","author":"Xu","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2023.111195_b0030","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1007\/s00281-022-00943-7","article-title":"Inflammatory Responses After Ischemic Stroke","volume":"44","author":"DeLong","year":"2022","journal-title":"Semin. Immunopathol."},{"key":"10.1016\/j.intimp.2023.111195_b0035","doi-asserted-by":"crossref","first-page":"147","DOI":"10.3389\/fnins.2015.00147","article-title":"Rational modulation of the innate immune system for neuroprotection in ischemic stroke","volume":"9","author":"Amantea","year":"2015","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.intimp.2023.111195_b0040","doi-asserted-by":"crossref","first-page":"S31","DOI":"10.3909\/ricm19S1S0002","article-title":"PCSK9 Inhibitors: Mechanism of Action, Efficacy, and Safety","volume":"19","author":"Roth","year":"2018","journal-title":"Rev Cardiovasc Med."},{"key":"10.1016\/j.intimp.2023.111195_b0045","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1038\/ng1509","article-title":"Low LDL cholesterol in individuals of African descent resulting from frequent nonsense mutations in PCSK9","volume":"37","author":"Cohen","year":"2005","journal-title":"Nat. Genet."},{"key":"10.1016\/j.intimp.2023.111195_b0050","doi-asserted-by":"crossref","first-page":"2054","DOI":"10.1161\/CIRCULATIONAHA.119.043826","article-title":"Effect of Alirocumab on Stroke in ODYSSEY OUTCOMES","volume":"140","author":"Jukema","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.intimp.2023.111195_b0055","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1056\/NEJMoa1615664","article-title":"Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease","volume":"376","author":"Sabatine","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.intimp.2023.111195_b0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.neubiorev.2023.105155","article-title":"Proprotein convertase subtilisin\/kexin type 9 (PCSK9) in the central nervous system","volume":"149","author":"Bell","year":"2023","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.intimp.2023.111195_b0065","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1194\/jlr.M800542-JLR200","article-title":"Function and distribution of circulating human PCSK9 expressed extrahepatically in transgenic mice","volume":"50","author":"Luo","year":"2009","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.intimp.2023.111195_b0070","doi-asserted-by":"crossref","first-page":"e010838","DOI":"10.1161\/JAHA.118.010838","article-title":"Pretreatment With PCSK9 Inhibitor Protects the Brain Against Cardiac Ischemia\/Reperfusion Injury Through a Reduction of Neuronal Inflammation and Amyloid Beta Aggregation","volume":"8","author":"Apaijai","year":"2019","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.intimp.2023.111195_b0075","doi-asserted-by":"crossref","first-page":"197","DOI":"10.2119\/molmed.2014.00199","article-title":"Acetylbritannilactone Modulates MicroRNA-155-Mediated Inflammatory Response in Ischemic Cerebral Tissues","volume":"21","author":"Wen","year":"2015","journal-title":"Mol. Med."},{"key":"10.1016\/j.intimp.2023.111195_b0080","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.894789","article-title":"Targeting PCSK9 Ameliorates Graft Vascular Disease in Mice by Inhibiting NLRP3 Inflammasome Activation in Vascular Smooth Muscle Cells","volume":"13","author":"Zou","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2023.111195_b0085","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1161\/CIRCULATIONAHA.121.056491","article-title":"Ablation of Plasma Prekallikrein Decreases Low-Density Lipoprotein Cholesterol by Stabilizing Low-Density Lipoprotein Receptor and Protects Against Atherosclerosis","volume":"145","author":"Wang","year":"2022","journal-title":"Circulation"},{"key":"10.1016\/j.intimp.2023.111195_b0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2022.102347","article-title":"The antioxidant enzyme Peroxiredoxin-1 controls stroke-associated microglia against acute ischemic stroke","volume":"54","author":"Kim","year":"2022","journal-title":"Redox Biol."},{"key":"10.1016\/j.intimp.2023.111195_b0095","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/jcbfm.1990.47","article-title":"A semiautomated method for measuring brain infarct volume","volume":"10","author":"Swanson","year":"1990","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.intimp.2023.111195_b0100","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/S1474-4422(19)30030-4","article-title":"The global burden of stroke: persistent and disabling","volume":"18","author":"Gorelick","year":"2019","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.intimp.2023.111195_b0105","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1186\/s12974-019-1516-2","article-title":"Neuroinflammation: friend and foe for ischemic stroke","volume":"16","author":"Jayaraj","year":"2019","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.intimp.2023.111195_b0110","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.tips.2020.11.010","article-title":"Targeting the Immune System for Ischemic Stroke","volume":"42","author":"Zhang","year":"2021","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.intimp.2023.111195_b0115","first-page":"5076","article-title":"Novel apoE receptor mimetics reduce LPS-induced microglial inflammation","volume":"11","author":"Wang","year":"2019","journal-title":"Am. J. Transl. Res."},{"key":"10.1016\/j.intimp.2023.111195_b0120","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1194\/jlr.M014118","article-title":"PCSK9 reduces the protein levels of the LDL receptor in mouse brain during development and after ischemic stroke","volume":"52","author":"Rousselet","year":"2011","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.intimp.2023.111195_b0125","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/ijc.2910600111","article-title":"nmb, a novel gene, is expressed in low-metastatic human melanoma cell lines and xenografts","volume":"60","author":"Weterman","year":"1995","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.intimp.2023.111195_b0130","doi-asserted-by":"crossref","first-page":"e12093","DOI":"10.1371\/journal.pone.0012093","article-title":"ADAM10 releases a soluble form of the GPNMB\/Osteoactivin extracellular domain with angiogenic properties","volume":"5","author":"Rose","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.intimp.2023.111195_b0135","doi-asserted-by":"crossref","first-page":"4573","DOI":"10.1038\/s41388-022-02443-2","article-title":"GPNMB: a potent inducer of immunosuppression in cancer","volume":"41","author":"Lazaratos","year":"2022","journal-title":"Oncogene."},{"key":"10.1016\/j.intimp.2023.111195_b0140","doi-asserted-by":"crossref","first-page":"6522","DOI":"10.1038\/s41598-022-10522-3","article-title":"Glycoprotein nonmetastatic melanoma protein B regulates lysosomal integrity and lifespan of senescent cells","volume":"12","author":"Suda","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.intimp.2023.111195_b0145","doi-asserted-by":"crossref","first-page":"eabk0637","DOI":"10.1126\/science.abk0637","article-title":"GPNMB confers risk for Parkinson's disease through interaction with \u03b1-synuclein","volume":"377","author":"Diaz-Ortiz","year":"2022","journal-title":"Science."},{"key":"10.1016\/j.intimp.2023.111195_b0150","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.neuroscience.2014.06.065","article-title":"Glycoprotein nonmetastatic melanoma protein B (GPNMB) as a novel neuroprotective factor in cerebral ischemia-reperfusion injury","volume":"277","author":"Nakano","year":"2014","journal-title":"Neuroscience"},{"key":"10.1016\/j.intimp.2023.111195_b0155","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1097\/00005072-199307000-00009","article-title":"CD44 expression in human astrocytes and oligodendrocytes in culture","volume":"52","author":"Moretto","year":"1993","journal-title":"J Neuropathol Exp Neurol."},{"key":"10.1016\/j.intimp.2023.111195_b0160","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/s12974-018-1100-1","article-title":"The glycoprotein GPNMB attenuates astrocyte inflammatory responses through the CD44 receptor","volume":"15","author":"Neal","year":"2018","journal-title":"J. Neuroinflammation"}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576923015229?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576923015229?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T18:12:38Z","timestamp":1761588758000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576923015229"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":32,"alternative-id":["S1567576923015229"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2023.111195","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"PCSK9 inhibitor protects against ischemic cerebral injury by attenuating inflammation via the GPNMB\/CD44 pathway","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2023.111195","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"111195"}}